NEW YORK, July 7, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global mRNA ...

Overview of Genomics in Cancer Care MarketThe global Genomics in Cancer Care Market is valued at USD 24.5 Billion in 2024 and ...

The global Liquid Biopsy Market is valued at USD 11.41 Billion in 2024 and is projected to reach a value of USD 30.65 Billion ...

Laboratory tinkerers have also hacked some of the new gene chips into platforms for analyzing the copy numbers of genes, revealing surprising new levels of complexity in genetic regulation.

Figure 2: Sequence coverage of targeted cancer genes obtained after a targeted Illumina NGS run using the HybSelect process. (a) Average depth of exon coverage of 115 individual cancer-related genes.

Illumina (NASDAQ:ILMN) stock dips as Scotiabank downgrades. However, peers Danaher (DHR) stock and Thermo Fisher (TMO) stock win upgrades. Read more here.

In biology textbooks and beyond, the human genome and DNA therein typically are taught in only one dimension. While it can be ...

Every living cell must interpret its genetic code - a sequence of chemical letters that governs countless cellular functions.

Every living cell must interpret its genetic code—a sequence of chemical letters that governs countless cellular functions. A ...

Illumina was also recognized as one of the Best Companies to Work For byU.S. News & World Report SAN DIEGO, July 10, 2025 /PRNewswire/ -- Illumina ...

Illumina (ILMN) stock downgraded to Sell while Charles River (CRL) stock and Hologic (HOLX) stock were upgraded to buy at Citi. Read more here.

Element Bio’s bid to take on Illumina in the DNA sequencing market has been helped by an impressive $277m financing round.